Attached files

file filename
EX-31.3 - EX-31.3 - Jazz Pharmaceuticals plcd520950dex313.htm
10-K/A - AMENDMENT NO. 1 TO FORM 10-K - Jazz Pharmaceuticals plcd520950d10ka.htm

EXHIBIT 31.4

CERTIFICATION

I, Kathryn E. Falberg, certify that:

 

  1. I have reviewed this Amendment No. 1 to the annual report on Form 10-K/A of Jazz Pharmaceuticals Public Limited Company; and

 

  2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report.

 

Date: April 24, 2013   By:   

/s/    KATHRYN E. FALBERG        

   

Kathryn E. Falberg

Executive Vice President and Chief Financial Officer